Capital Fund Management S.A. Regenxbio Inc. Transaction History

Capital Fund Management S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$27.01 - $40.26 $523,642 - $780,520	-19,387 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.75 - $43.44 $337,828 - $528,838	12,174 Added 168.78%	19,387 $714,000
Q1 2020 May 13, 2020	BUY	$21.5 - $54.2 $155,079 - $390,944	7,213 New	7,213 $233,000
Q2 2019 Aug 12, 2019	SELL	$42.0 - $59.29 $177,282 - $250,263	-4,221 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$40.82 - $62.45 $172,301 - $263,601	4,221 New	4,221 $242,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.